These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. High-level artemisinin-resistance with quinine co-resistance emerges in P. falciparum malaria under in vivo artesunate pressure. Tyagi RK; Gleeson PJ; Arnold L; Tahar R; Prieur E; Decosterd L; Pérignon JL; Olliaro P; Druilhe P BMC Med; 2018 Oct; 16(1):181. PubMed ID: 30269689 [TBL] [Abstract][Full Text] [Related]
6. Artemisinin Resistance and Stage Dependency of Parasite Clearance in Falciparum Malaria. Intharabut B; Kingston HW; Srinamon K; Ashley EA; Imwong M; Dhorda M; Woodrow C; Stepniewska K; Silamut K; Day NPJ; Dondorp AM; White NJ; J Infect Dis; 2019 Apr; 219(9):1483-1489. PubMed ID: 30657916 [TBL] [Abstract][Full Text] [Related]
7. Contribution of Functional Antimalarial Immunity to Measures of Parasite Clearance in Therapeutic Efficacy Studies of Artemisinin Derivatives. O'Flaherty K; Ataíde R; Zaloumis SG; Ashley EA; Powell R; Feng G; Reiling L; Dondorp AM; Day NP; Dhorda M; Fairhurst RM; Lim P; Amaratunga C; Pukrittayakamee S; Hien TT; Htut Y; Mayxay M; Faiz MA; Beeson JG; Nosten F; Simpson JA; White NJ; Fowkes FJI J Infect Dis; 2019 Aug; 220(7):1178-1187. PubMed ID: 31075171 [TBL] [Abstract][Full Text] [Related]
8. Population pharmacokinetic and pharmacodynamic properties of artesunate in patients with artemisinin sensitive and resistant infections in Southern Myanmar. Lohy Das JP; Kyaw MP; Nyunt MH; Chit K; Aye KH; Aye MM; Karlsson MO; Bergstrand M; Tarning J Malar J; 2018 Mar; 17(1):126. PubMed ID: 29566683 [TBL] [Abstract][Full Text] [Related]
9. Intrahost modeling of artemisinin resistance in Plasmodium falciparum. Saralamba S; Pan-Ngum W; Maude RJ; Lee SJ; Tarning J; Lindegårdh N; Chotivanich K; Nosten F; Day NP; Socheat D; White NJ; Dondorp AM; White LJ Proc Natl Acad Sci U S A; 2011 Jan; 108(1):397-402. PubMed ID: 21173254 [TBL] [Abstract][Full Text] [Related]
10. Plasmodium falciparum clearance is rapid and pitting independent in immune Malian children treated with artesunate for malaria. Ndour PA; Lopera-Mesa TM; Diakité SA; Chiang S; Mouri O; Roussel C; Jauréguiberry S; Biligui S; Kendjo E; Claessens A; Ciceron L; Mazier D; Thellier M; Diakité M; Fairhurst RM; Buffet PA J Infect Dis; 2015 Jan; 211(2):290-7. PubMed ID: 25183768 [TBL] [Abstract][Full Text] [Related]
11. An artesunate pharmacometric model to explain therapeutic responses in falciparum malaria. Saralamba S; Simpson JA; Choosri N; White L; Pan-Ngum W; Dondorp AM; White NJ J Antimicrob Chemother; 2023 Sep; 78(9):2192-2202. PubMed ID: 37473441 [TBL] [Abstract][Full Text] [Related]
12. Isolation and structure elucidation of a steroidal moiety from Pradhan D; Biswasroy P; Sahu DK; Ghosh G; Rath G J Biomol Struct Dyn; 2023 Jul; 41(11):4993-5006. PubMed ID: 35585777 [TBL] [Abstract][Full Text] [Related]
13. Defining the in vivo phenotype of artemisinin-resistant falciparum malaria: a modelling approach. White LJ; Flegg JA; Phyo AP; Wiladpai-ngern JH; Bethell D; Plowe C; Anderson T; Nkhoma S; Nair S; Tripura R; Stepniewska K; Pan-Ngum W; Silamut K; Cooper BS; Lubell Y; Ashley EA; Nguon C; Nosten F; White NJ; Dondorp AM PLoS Med; 2015 Apr; 12(4):e1001823. PubMed ID: 25919029 [TBL] [Abstract][Full Text] [Related]
14. Reduced susceptibility of Plasmodium falciparum to artesunate in southern Myanmar. Kyaw MP; Nyunt MH; Chit K; Aye MM; Aye KH; Aye MM; Lindegardh N; Tarning J; Imwong M; Jacob CG; Rasmussen C; Perin J; Ringwald P; Nyunt MM PLoS One; 2013; 8(3):e57689. PubMed ID: 23520478 [TBL] [Abstract][Full Text] [Related]
15. Assessment of parasite clearance following treatment of severe malaria with intravenous artesunate in Ugandan children enrolled in a randomized controlled clinical trial. Byakika-Kibwika P; Nyakato P; Lamorde M; Kiragga AN Malar J; 2018 Oct; 17(1):400. PubMed ID: 30376860 [TBL] [Abstract][Full Text] [Related]
16. Local emergence in Amazonia of Mathieu LC; Cox H; Early AM; Mok S; Lazrek Y; Paquet JC; Ade MP; Lucchi NW; Grant Q; Udhayakumar V; Alexandre JS; Demar M; Ringwald P; Neafsey DE; Fidock DA; Musset L Elife; 2020 May; 9():. PubMed ID: 32394893 [TBL] [Abstract][Full Text] [Related]
17. Optimal Treatments for Severe Malaria and the Threat Posed by Artemisinin Resistance. Jones S; Hodel EM; Sharma R; Kay K; Hastings IM J Infect Dis; 2019 Apr; 219(8):1243-1253. PubMed ID: 30517708 [TBL] [Abstract][Full Text] [Related]
18. Monitoring for Plasmodium falciparum drug resistance to artemisinin and artesunate in Binh Phuoc Province, Vietnam: 1998-2009. Thanh NV; Toan TQ; Cowman AF; Casey GJ; Phuc BQ; Tien NT; Hung NM; Biggs BA Malar J; 2010 Jun; 9():181. PubMed ID: 20573274 [TBL] [Abstract][Full Text] [Related]
19. Artemisinin-resistant Plasmodium falciparum in Pursat province, western Cambodia: a parasite clearance rate study. Amaratunga C; Sreng S; Suon S; Phelps ES; Stepniewska K; Lim P; Zhou C; Mao S; Anderson JM; Lindegardh N; Jiang H; Song J; Su XZ; White NJ; Dondorp AM; Anderson TJ; Fay MP; Mu J; Duong S; Fairhurst RM Lancet Infect Dis; 2012 Nov; 12(11):851-8. PubMed ID: 22940027 [TBL] [Abstract][Full Text] [Related]
20. Host immunity to Ataide R; Ashley EA; Powell R; Chan JA; Malloy MJ; O'Flaherty K; Takashima E; Langer C; Tsuboi T; Dondorp AM; Day NP; Dhorda M; Fairhurst RM; Lim P; Amaratunga C; Pukrittayakamee S; Hien TT; Htut Y; Mayxay M; Faiz MA; Beeson JG; Nosten F; Simpson JA; White NJ; Fowkes FJ Proc Natl Acad Sci U S A; 2017 Mar; 114(13):3515-3520. PubMed ID: 28289193 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]